Tylvax TIMES MORE POWERFUL. One step ahead. Tylvalosin (as tartrate) Poultry and Swine Division Agrovet Market Animal Health

Similar documents
ANTIBIOTICS COLIPHyL A.U.V. 8

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Poultry Drugs. Amoxicillin W.S.P 20% W.S.Powder 1. Amoxicillin W.S.P 50% W.S.Powder 2. Cotusin-666 W.S.Powder 3. Doxin-200 W.S.

RESERVED FOR VETERINARY SURGEONS - 06/2005

SUMMARY OF PRODUCT CHARACTERISTICS

9081V 9082V 9032V 9291V 9310V 9321V V

Doxivex, 100 mg/ml concentrate for oral solution for chickens and pigs

Colisepticaemia Fowl cholera Infectious arthritis Cystitis Dermatitis Bronchitis

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Vetmulin 450 mg/g granules for use in drinking water for pigs. (All MS except FR)

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine

form Denagard 10% Premix 100mg/g Pigs Oral Tiamutin 10% premix ad us.vet. Premix 100mg/g Pigs Chickens Turkeys

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PFIZER ANIMAL HEALTH Product Name: LINCO-SPECTIN"" ANTIBIOTIC INJECTABLE SOLUTION Date: 1 November 2011 Page 1 of 9

SUMMARY OF PRODUCT CHARACTERISTICS

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

The Use of Antibiotics in the Poultry Industry

SUMMARY OF PRODUCT CHARACTERISTICS. Pharmasin 250 mg/g Premix for medicated feeding stuff for pigs, broilers and pullets

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

SUMMARY OF PRODUCT CHARACTERISTICS. KARIDOX 100 mg/ml oral solution for use in drinking water for chickens and pigs [UK, ES, IT, NL, DK, RO]

Enteric Clostridia 10/27/2011. C. perfringens: general. C. perfringens: Types & toxins. C. perfringens: Types & toxins

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Abx II: Inhibitors of Protein Synthesis. Aminoglycosides/Aminocyclitols Gentamicin/Streptomycin, Spectinomycin. VPM 201: Lewis-11: Abx II

Enteric Clostridia. C. perfringens: general

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

Pathogens commonly isolated from selected diseases

towards a more responsible antibiotics use in asian animal production: supporting digestive health with essential oil compounds TECHNICAL PAPER

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

625mg/g Water Soluble Granules For use in drinking water for chickens and for turkeys

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

Alternatives to Antibiotics

SUMMARY OF PRODUCT CHARACTERISTICS

Portec Australia Gilt Edge Resources Pty Ltd A.C.N

Summary of Product Characteristics

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy

Improves pig performance in a wide range of health and growing conditions. (neomycin/oxytetracycline)

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

supplied with its solvent for more practical use

(oxytetracycline HCI)

PHARMACOKINETICS - ANTIMICROBIAL SENSITIVITY AND RESISTANCE

Unique, fast-acting, and long-lasting injectables for livestock health & nutrition

PHARMACOKINETICS, MINIMAL INHIBITORY CONCENTRATIONS AND EFFICACY MODEL RELATIONSHIPS FOR SOME GUT INFECTIONS IN PIGS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

CONTROLLING ILEITIS IN THE COLITIS COMPLEX

SUMMARY OF PRODUCT CHARACTERISTICS

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Hello to Aivlosin, the brand new macrolide antibiotic

Healthy animals, safe food but to what extent is antimicrobial use in pig production a cause for concern?

SUMMARY OF PRODUCT CHARACTERISTICS. CEFOKEL 50 mg/ml, suspension for injection for pigs and cattle

SUMMARY OF PRODUCT CHARACTERISTICS

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

B. PACKAGE LEAFLET 1

Use of Antibiotics. In Food-Producing Animals: A Survey of Ontario Veterinarians Involved with. Food-Producing Animal Practice

Summary of Product Characteristics

Octagon Services Ltd, Old Windsor, Berkshire, United Kingdom

UPDATES ON ANTIBIOTIC THERAPY. Jennifer L. Davis, DVM, PhD, DACVIM (LA), DACVCP VA-MD College of Veterinary Medicine VA Tech, Blacksburg, VA

Domestic Turkey Diseases

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS AND LABEL/LEAFLET

COCCIDIOSIS FROM DAY

QMS Pigs Assurance Scheme Compliance Version July Name and postcode of unit.. Name of unit(s)... QMS membership number(s).. Slap mark(s)..

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

Nicholas Schneider, DVM Schneider Veterinary Services, LLC. Milliken, CO

2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, st February 2017.

Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion

SUMMARY OF PRODUCT CHARACTERISTICS

Is erythromycin bactericidal

ANTIMICROBIAL USE IN POULTRY PRODUCTION

1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Ceftiocyl 50 mg/ml, suspension for injection for cattle and pigs

Antibiotic Use in Animal Health

A long-acting, broad spectrum, injectable antibiotic for the treatment and control of

Summary of Product Characteristics

Approved by the Food Safety Commission on September 30, 2004

Copy in the header and footer will not appear on the final printed label LAB0042 Prepared: 28/02/01 SYRINGE LABEL

Antibiotics & Resistance

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

Summary of Product Characteristics

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

SUMMARY OF PRODUCT CHARACTERISTICS

Is ABF production supporting or contradicting bird welfare? Maarten De Gussem, DVM Poultry Vaccinology - Ceva Summit March 14th 2016, Barcelona

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Marbotab P 20 mg tablets for dogs and cats

Survey of Tiamulin+Oxytetracyclinein control of CRD complex due to La Sota vaccine in broiler chickens

Transcription:

Tylvax One step ahead Tylvalosin (as tartrate) The minimum inhibitory concentration (MIC) of tylvalosin is 10 times lower than tylosin against Mycoplasma hyopneumoniae. In reference values tylvalosin MIC <0.0125 vs. Tylosin MIC = 0.1. TIMES MORE POWERFUL Poultry and Swine Division Agrovet Market Animal Health

DISCOVER THE MAXIMUM POWER IN THE CONTROL OF RESPIRATORY AND ENTERIC DISEASES Poultry and Swine Division Agrovet Market Animal Health

Tylvax One step ahead We are introducing an innovative portfolio of products based on Acetylisovaleryltylosin macrolide antibiotic, better known as tylvalosin (on tartrate form). Tylvalosin has a rapid absorption, excellent bioavailability, achieving very high concentrations in blood and target tissues. It has a powerful mycoplasmicide effect ten times higher than tylosin. Tylvax is recommended for the prevention and effective treatment of the disease caused by Mycoplasma and enteric diseases in poultry - chickens and turkeys - and pigs. Tylvax Px Tylvax C Px Tylvax WS Advanced-generation macrolide antibiotic Tylvalosin (as tartrate) 5 % Advanced-generation and broad-spectrum tetracycline - macrolide synergyc association Tylvalosin (as tartrate) 2 % Chlortetracycline (as hydrochloride) 20 % Advanced-generation macrolide antibiotic Tylvalosin (as tartrate) 25 %

Tylvax One step ahead Powerful mycoplasmicide effect / Its powerful effect achieves bactericidal action at a minimum concentration and in a shorter period of time. Tylvax has a powerful mycoplasmicide effect: ten times higher than tylosin. Fast and effective response / Tylvalosin has shown to have a very fast absorption. In just 30 to 60 minutes (chickens and pigs respectively) it reaches therapeutic plasmatic levels. In comparison, tylosin requires twice as long to achieve lower levels. Tylvax is highly effective in the control and treatment of major infectious diseases in pigs.

A superior MOLECULE Selective action on target tissues / Tylvax is highly effective against respiratory and enteric pathogens, accumulating in the tissues in a selective way, reaching pulmonary and mucosal lining concentrations higher than plasmatic concentration. Also, by concentrating in bile, it guarantees its presence in the digestive tract against enteric pathogens. Its action is effective in more than one location / Tylvalosin present in Tylvax binds to bacterial ribosome, preventing the development of protein synthesis, thereby causing inhibition of bacterial growth or death. In addition, the main metabolite binds to another receptor of the bacterial ribosome, ensuring powerful action. It improves conversion rates / Ideal growth promoter, improves conversion rates and production efficiency. Antibiotic effect at intra and extra cellular levels / Tylvalosin rapidly reaches high intracellular concentrations. Similarly, if the concentration in the extracellular environment is lower than in the intracellular space, the drug is released from inside of the cell, enhancing the antibacterial action both intracellular and extracellularly. Improves non-specific immunity / Tylvax can increase the activity of macrophages, helping the non-specific immune system to remove pathogen agents. Tylvalosin makes macrophages more active and stimulates the differentiation of monocytes to macrophages.

Tylvax One step ahead Mycoplasmicide action / The action of tylvalosin in Tylvax is ten times stronger than tylosin since its minimum inhibitory concentration (MIC) is ten times lower against Mycoplasma hyopneumoniae. Sensitivity test of Mycoplasma hyopneumoniae 1 Antibiotic Yamamato MIC 90 µg/ml Inamoto MIC 90 µg/ml Tylvalosin <0.013 <0.0125 Tylosin 0.1 0.1 MIC: minimum inhibitory concentration Tylvax provides reliable results in the prevention and treatment of mycoplasmosis. 1 External bibliography.

POWER AND ACTION Wide range of action / Tylvax is indicated for the control of respiratory and enteric diseases in poultry and pigs. Tylvalosin in Tylvax has antibacterial activity against gram positive and some gram negative microorganisms, having also excellent antimycoplasmal activity. Tylvax C Px is a proposal of unique formulation based on the synergic combination of chlortetracycline and tylvalosin. Chlortetracycline, of bacteriostatic action, increases the antibiotic effect and enhances the action of tylvalosin. Tylvax C Px is indicated for treatment and prevention of: Poultry - Chickens and turkeys Poultry - Chickens and turkeys Mycoplasmosis Necrotic enteritis ORT Pigs Mycoplasmal pneumonia (Enzootic) PPE (Ileitis) Swine dysentery Swine colitis Mycoplasmosis Necrotic enteritis, bacterial enteritis ORT Colisepticemia Infectious coryza Fowl cholera Pneumonias Omphalitis Coccidiosis (Eimeria spp.) Salmonellosis Infectious synovitis Secondary bacterial infections Pigs Mycoplasmosis PPE (Ileitis) Swine dysentery Atrophic rhinitis Swine colitis

Tylvax used as growth promoter can improve productive parameters.

EFFECTIVENESS AND EFFICIENCY Excellent therapeutic / Studies to evaluate the therapeutic effectiveness of Tylvax C Px have demonstrated: % of cumulative survival 101 100 99 98 97 96 95 94 93 92 91 0 4 8 12 16 20 24 28 32 36 39 Experimental days Tylvax C Px Control Effec of Tylvax C Px on mortality of turkeys positive to Mycoplasma gallisepticum 3. 100% protection rate against Mycoplasma gallisepticum in chickens 2 and 99% in turkeys 3. Improvement in the survival rate of infected birds by Mycoplasma gallisepticum (with respect to the control groups): 100% in chickens 2, 99.20% in chickens and 99.8% in turkeys 3. Prevents sinusitis and clinical signs caused by Mycoplasma gallisepticum in turkeys for a period of 30 days post-treatment, with a difference of 16% over the control group. 3 Productive efficiency / Tylvalosin present in Tylvax, alone or associated, is capable of optimizing production parameters. Studies indicate that when used as growth promoter: It improves conversion rates and production efficiency versus control groups, as much as tylvalosin alone or associated to chlortetracycline. 4 1.7 1.6 1.5 1.4 1.3 1.2 1.1 1 0.9 1.452 1.346 1.31 1.194 1.175 0.981 0.952 1.695 1.582 1.658 1.534 1.438 Tylvax C Px Control Effect of Tylvax C Px on the evolution of Feed Conversion Ratio (FCR) in broiler chickens under controlled breeding conditions. 4 420 400 380 360 340 320 300 384.231 401.809 323.537 318.115 351.013 362.685 Tylvax C Px Control Effect of Tylvax C Px on the Productive Efficiency Ratio (PER) in broiler chickens under controlled breeding conditions 4 0 2 3 4 5 6 Male Female Mixed Weeks 2 Therapeutic test of acetyl - isovaleryl - tylosin soluble powder to artificial air sacculitis chicken infectious. 2012. 3 Evaluation of the effectiveness of Tylvax Px against field strains of Mycoplasma gallisepticum in turkeys. Angelats, Roxana. AMAH. Lima 2014 4 Effect of tylvalosin ( Tylvax Px ) and tylvalosin + chlortetracycline ( Tylvax C Px ) on production parameters of broiler chickens. Figueroa, Gastón, FMV UNMSM. Lima 2014.

Tylvax Px Premix Advanced-Generation Macrolide Antibiotic for Administration in Feed. Composition / Each 100 g contains: Tylvalosin (Acetyl-Isovaleryl) as tartrate... 5 g Excipients q.s. ad..... 100 g Indications / Treatment and prevention of respiratory, enteric and other diseases, mainly caused by microorganisms sensitive to tylvalosin. Poultry / Chickens and turkeys / Micoplasmosis: Mycoplasma gallisepticum, Mycoplasma synoviae and Mycoplasma meleagridis. Chronic Respiratory Disease (CRD) caused by M. gallisepticum. Necrotic enteritis associated to Clostridium perfringens, bacterial enteritis. ORT (Ornithobacterium rhinotracheale). Pigs / Micoplasmosis, Mycoplasmal pneumonia (enzootic) caused by M. hyopneumoniae. Porcine Proliferative Enteropathy (PPE), swine ileitis caused by Lawsonia intracellularis. Swine dysentery caused by Brachyspira hyodysenteriae. Swine colitis caused by Brachyspira pilosicoli. Withdrawal period / Pigs: 2 days. Poultry - Chickens and turkeys: 3 days. Do not administer to birds laying eggs for human consumption.

TIMES MORE POWERFUL * Dosage and administration / Tylvax Px has to be administered orally mixed in feed at the following concentrations: Poultry - Chickens, turkeys and replacement pullets Pathologles Quantity of active ingredient per ton of feed Inclusion rate of Tylvax Px in feed Duration of treatment Preventive Infections by mycoplasma Other infections by susceptible germs 20-50* g (20-50* ppm) 50 g (50 ppm) 400-1000 g/ton 1 kg/ton 7 first days 7 days Terapeutic Infections by mycoplasma Other infections caused by susceptible germs 50-100 g (50-100 ppm) 1-2 kg/ton 7-10 days In periods of stress: 5-7 additional days Swine Pathologles Dosage mg/kg/animal Quantily of active ingredient per ton of feed Inclusion rate of Tylvax Px in feed Duration of treatment Swine enzootic pneumonia 0.85 mg/kg/day 20 g (20 ppm) 400 g/ton Preventive PPE (ileitis) Swine dysentery 0.85-2.125 mg/kg/day 20-50*g (20-50*ppm) 400-1000 g/ton 2.125 mg/kg/day 50 g (50 ppm) 1 kg/ton 21 days or up to the end of risk period Other infections caused by susceptible germs 0.85-2.125 mg/kg/day 20-50**g (20-50** ppm) 400-1000 g/ton Swine enzootic pneumonia 2.125 mg/kg/day 50 g (50 ppm) 1 kg/ton 7 days Therapeutic PPE (ileitis) Swine Dysentery 2.125-4.25 mg/kg/day 50-100 g (50-100 ppm) 1-2 kg/ton 10-14 days Other infections caused by susceptible germs * Piglets: 20 ppm up to 25 kg. Sows: 50 ppm during 10 days before delivery. Sucking pigs over 25 kg: 50 ppm the first week and then 20 ppm during 8 weeks. ** 50 ppm when the risk is high or under conditions of stress. For more information on dosage, consult the product insert. One step ahead

Tylvax C Px UNIQUE PRODUCT Premix Advanced-Generation and Broad Spectrum Macrolide + Tetracycline Synergic Association for Medication in Feed. Composition / Each 100 g contains: Tylvalosin (Acetyl-Isovaleryl) as tartrate... 2 g Chlortetracycline (as hydrochloride)..... 20 g Excipients q.s. ad..... 100 g Indications / 1 Kg 100 g 20 Kg Treatment and prevention of respiratory, enteric and other diseases, mainly caused by microorganisms sensitive to tylvalosin and/or chlortetracycline. Poultry / Chickens and Turkeys / Chronic Respiratory Disease (CRD), air sacculitis and infectious sinusitis caused by Mycoplasma gallisepticum, Mycoplasma synoviae and Mycoplasma meleagridis (turkeys). Necrotic enteritis associated to Clostridium perfringens, bacterial enteritis. ORT (Ornithobacterium rhinotracheale). Colisepticemia. Infectious coryza. Fowl cholera - Pneumonia - Omphalitis - Infectious synovitis. Secondary bacterial infections due to virus, coccidia (Eimeria spp.). E. coli secondary infections associated to rhinotracheitis in turkeys. Stress or early mortality due to unspecified reasons. In periods of stress, to keep body weight gain. Pigs / Mycoplasmosis, mycoplasmal pneumonia (enzootic) caused by M. hyopneumoniae. Porcine Proliferative Enteropathy (PPE), swine ileitis caused by Lawsonia intracellularis. Swine dysentery caused by Brachyspira hyodysenteriae. Swine colitis caused by Brachyspira pilosicoli. Atrophic rhinitis, pneumonia, swine pleuropneumonia. Glässer disease, infectious synovitis, necrotic and infectious enteritis of diverse pathologies (Salmonellosis, Colibacillosis). Streptococcal lymphadenitis (cervical abscesses) and joints abscesses (Staphylococcus spp., Corynebacterium spp., Streptococcus spp.). Secondary bacterial infections due to virus or mycoplasmosis. To maintain body weight gain during periods of stress.

TIMES MORE POWERFUL * Dosage and administration / Tylvax C Px has to be administered orally mixed with food according to the following concentrations: Poultry - Chickens, turkeys and replacement pullets Quantity of active ingredient per ton of feed Inclusion rate of Tylvax C Px in feed Duration of treatment Preventive 20 ppm of tylvalosin 200 ppm of chlortetracycline 1 kg/ton 7-14 days Therapeutic 50 ppm of tylvalosin 500 ppm of chlortetracycline 2.5 kg/ton 7-10 days In periods of stress: 5-7 additional days Swine Quantity of active ingredient per ton of feed Inclusion rate of Tylvax C Px in feed Duration of treatment Preventive 20 ppm of tylvalosin 200 ppm of chlortetracycline 1 kg/ton* 21 days or until the end of the risk period Therapeutic 50 ppm of tylvalosin 500 ppm of chlortetracycline 2.5 kg/ton** 7-10 days (up to 14 days) * Up to 2.5 Kg/Ton when the risk is high or under conditions of stress. ** Up to 4 Kg/Ton in cases of very serious infections and/or with additional situations of stress. For more information on dosage consult the insert of the product.. Withdrawal period / Meat: 5 days. Do not administer to birds laying eggs for human consumption. The association based on tylvalosin with chlortetracycline has demonstrated more effectiveness in the prevention of mycoplasmosis in comparison to the treatment based on the combination of tiamulin with chlortetracycline, offering a longer period of protection at the end of the treatment in turkeys. 3 One step ahead 3 Evaluation of the effectiveness of Tylvax Px against field strains of Mycoplasma gallisepticum in turkeys. Angelats, Roxana. AMAH. Lima 2014.

Tylvax WS Water Soluble Advanced-Generation Macrolide Antibiotic for Administration in Drinking Water Composition / Each 100 g contains: Tylvalosin (Acetyl-Isovaleryl) as tartrate... 25 g Excipients q.s. ad..... 100 g Indications / Treatment and prevention of respiratory, enteric and other diseases, mainly caused by microorganisms sensitive to tylvalosin. Poultry / Chickens and turkeys / Micoplasmosis: Mycoplasma gallisepticum, Mycoplasma synoviae and Mycoplasma meleagridis. Chronic Respiratory Disease (CRD) caused by M. gallisepticum. Necrotic enteritis associated to Clostridium perfringens, bacterial enteritis. ORT (Ornithobacterium rhinotracheale). Pigs / Mycoplasmosis, Mycoplasmal pneumonia (enzootic) caused by M. hyopneumoniae. Porcine Proliferative Enteropathy (PPE), swine ileitis caused by Lawsonia intracellularis. Swine dysentery caused by Brachyspira hyodysenteriae. Swine colitis caused by Brachyspira pilosicoli. Withdrawal period / Meat: 2 days. Do not administer to birds laying eggs for human consumption. Not to be used within 14 days before laying date.

TIMES MORE POWERFUL * Dosage and administration / Tylvax WS has to be administered orally in drinking water at the following concentrations: Poultry - Chickens, turkeys and replacement pullets Dosage of tylvalosin per kg of body weight Quantity of active ingredient per 1,000 L of water Inclusion rate of Tylvax WS in water Duration of treatment Preventive 20-25 mg/kg. 10-15 mg/kg. 100-125 g (100-125 ppm) 50-75 g (50-75 ppm) 80-100 g/200 L. 40-60 g/200 L. First 3 days of life 3-4 additional days in stress situations and/or 3-4 days each month Therapeutic 20-25 mg/kg. 100-125 g (100-125 ppm) 80-100 g/200 L. 3 days Swine Dosage of tylvalosin per kg of body weight Quantity of active ingredient per 1,000 L of water Inclusion rate of Tylvax WS in water Duration of treatment Preventive 5 mg/kg. 50 g (50 ppm) 100 g/500 L. 3-4 days General therapeutic 5-10 mg/kg. 50-100 g (50-100 ppm) 100-200 g/500 L. 3-5 days Therapeutic PPE (ileitis) 5 mg/kg. 50 g (50 ppm) 100 g/500 L. 5 days Note: Assuming a daily water consumption per pig equivalent to 10% of its weight. For more information on dosage consult the insert of the product. One step ahead

Powerful mycoplasmicide effect ten times higher than tylosin* TIMES MORE POWERFUL

Registered trademarks of Agrovet Market Animal Health Poultry and Swine Division Agrovet Market Animal Health Unique Veterinary Products Productos Veterinarios de Clase Única www.tilvalosina.com Use medications responsibly. Always consult a specialist before any treatment. For more information please contact: sales@agrovetmarket.com 511 2 300 300 www.agrovetmarket.com Av. Canadá 3792-3798 - San Luis - Lima - Perú